• Connective Tissue Disease Profile (Extractable Nuclear Antigen Antibody Panel)
  • Nalbuphine, Urine
  • F2-Isoprostanes, Urine
  • Hydromorphone, Urine
  • BCR-ABL Translocation by RT-PCR, Quantitative, Bone Marrow
  • Human Papillomavirus (HPV), Low-Risk, DNA In Situ Hybridization
  • West Nile Virus (WNV) Molecular Detection, Real-time PCR
  • Allergen Specific IgE, Respiratory (Environmental Inhalant) Profile
  • Diazepam, Urine
  • Hemosiderin Stain, Urine
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
Medical Test

Turnaround Time
Access to Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis is restricted.
Loading...